// App-Quantinova.ai

3349 : Differential expression of CD44 and CD24 markers discriminates the epithelioid from fibroblastoid subset in a sarcomatoid renal cell carcinoma cell line: evidence of the existence of cancer stem cells in both subsets

Researchers

Presenter

  • Chin-Hsuan Hsieh

Principal Investigators

  • Cheng-Keng Chuang

  • See-Tung Pang

  • Samuel Chien

  • Paul Lin

  • Shuen-Kuei Liao

Medical Centers

  • Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

  • Chang Gung Memorial Hospital, Taipei, Taiwan

  • Kai Fu Biotech Co. Ltd., Guanzhou, China

  • Taipei Medical University, Taipei, Taiwan

Locations

  • Taiwan

  • China

Companies

  • Kai Fu Biotech Co. L

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 105 Antigen

  • Cluster of Differentiation 24

  • Cluster of Differentiation 44

  • Matrilysin

  • Matrix metalloproteinase 2

  • TIMP Metallopeptidase Inhibitor 1

  • TIMP Metallopeptidase Inhibitor 2

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • TIMP-2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved